Author:
Cohen-Cymberknoh Malena,Garber Keren Marks,Reiter Joel,Shteinberg Michal,Stolovas Aielet,Barghouti Iyad,Adler Lazarovits Chana,Esh Broder Efrat,Hershko Klement Anat
Abstract
Abstract
Background
Over the past two decades, increasing number of people with cystic fibrosis (CF) survive into adulthood. Compared to the general population, sub-fertility is an obstacle for many women with CF (wwCF). Decreased ovarian reserve has been proposed as a possible cause, but limited data is available to support this. The aim of this study was to evaluate the ovarian reserve in wwCF and to correlate this with patients’ demographic and clinical data.
Methods
Reproductive-aged wwCF were enrolled during their routine medical appointments. Assessment included Anti-Mullerian hormone (AMH) levels, routine blood tests and antral follicular count (AFC) evaluation. Additionally, demographic, and clinical information were collected.
Results
A total of wenty-three wwCF were enrolled, with ages ranging from 19 to 40 years (median 27 years). Among the fourteen wwCF who were considering pregnancy, five (35.7%) disclosed undergoing an infertility assessment and receiving fertility treatments. All but one patient had an Anti-Mullerian hormone (AMH) level between the 5th and 95th % for age. Measurement of the antral follicular count (AFC) was possible in 12 of the 23 patients and was ranging 8–40 with a median of 17. The proportion of wwCF presenting below median AMH values was not different in sub-fertile as compared to fertile wwCF (P value 0.54). There were no correlations between AMH levels and disease severity parameters. AMH seemed to be relatively higher in wwCF with mild class mutations, but this was not shown to have statistical significance.
Conclusions
Our results, in contrast with the limited available published data, do not support the hypothesis that decreased ovarian reserve plays a major role in infertility in wwCF.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Oncology
Reference22 articles.
1. Marshall B, Faro A, Whitney B, Elbert A, Fink A, Cromwell E, et al. Cystic Fibrosis Foundation Patient Registry 2020 Annual Data Report. Bethesda, Maryland: Cystic Fibrosis Foundation; 2021.
2. Durieu I, Nove-Josserand R. Patients becoming parents: reproduction and pregnancy. Living Longer with CF Vol European Cystic Fibrosis Society2015. p. 119 – 26.
3. Cohen-Cymberknoh M, Gindi Reiss B, Reiter J, Lechtzin N, Melo J, Perez G, et al. Baseline cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression. J Cyst Fibros. 2021;20(3):388–94.
4. Shteinberg M, Lulu AB, Downey DG, Blumenfeld Z, Rousset-Jablonski C, Perceval M, et al. Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age. J Cyst Fibros. 2019;18(4):525–9.
5. Anthony E, Oppenheimer, Case AL, Esterly JR, Rothberg RM. Cervical mucus in cystic fibrosis: a possible cause of infertility. Am J Obstet Gynecol. 1970;108(4):673–4.